CN110448727B - A kind of viscous hydrogel material, suture-free artificial nerve conduit and preparation method thereof - Google Patents
A kind of viscous hydrogel material, suture-free artificial nerve conduit and preparation method thereof Download PDFInfo
- Publication number
- CN110448727B CN110448727B CN201910874185.1A CN201910874185A CN110448727B CN 110448727 B CN110448727 B CN 110448727B CN 201910874185 A CN201910874185 A CN 201910874185A CN 110448727 B CN110448727 B CN 110448727B
- Authority
- CN
- China
- Prior art keywords
- nerve conduit
- artificial nerve
- mixed solution
- chitosan
- suture
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 210000005036 nerve Anatomy 0.000 title claims abstract description 56
- 239000000017 hydrogel Substances 0.000 title claims abstract description 51
- 239000000463 material Substances 0.000 title claims abstract description 32
- 238000002360 preparation method Methods 0.000 title claims abstract description 14
- 229920001661 Chitosan Polymers 0.000 claims abstract description 42
- 238000000034 method Methods 0.000 claims abstract description 5
- ROOXNKNUYICQNP-UHFFFAOYSA-N ammonium persulfate Chemical compound [NH4+].[NH4+].[O-]S(=O)(=O)OOS([O-])(=O)=O ROOXNKNUYICQNP-UHFFFAOYSA-N 0.000 claims description 36
- 239000011259 mixed solution Substances 0.000 claims description 29
- KWYHDKDOAIKMQN-UHFFFAOYSA-N N,N,N',N'-tetramethylethylenediamine Chemical compound CN(C)CCN(C)C KWYHDKDOAIKMQN-UHFFFAOYSA-N 0.000 claims description 20
- 229910001870 ammonium persulfate Inorganic materials 0.000 claims description 18
- FPQQSJJWHUJYPU-UHFFFAOYSA-N 3-(dimethylamino)propyliminomethylidene-ethylazanium;chloride Chemical compound Cl.CCN=C=NCCCN(C)C FPQQSJJWHUJYPU-UHFFFAOYSA-N 0.000 claims description 16
- ZIUHHBKFKCYYJD-UHFFFAOYSA-N n,n'-methylenebisacrylamide Chemical compound C=CC(=O)NCNC(=O)C=C ZIUHHBKFKCYYJD-UHFFFAOYSA-N 0.000 claims description 16
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 claims description 15
- 239000007987 MES buffer Substances 0.000 claims description 14
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 claims description 13
- 235000010413 sodium alginate Nutrition 0.000 claims description 13
- 239000000661 sodium alginate Substances 0.000 claims description 13
- 229940005550 sodium alginate Drugs 0.000 claims description 13
- NQTADLQHYWFPDB-UHFFFAOYSA-N N-Hydroxysuccinimide Chemical compound ON1C(=O)CCC1=O NQTADLQHYWFPDB-UHFFFAOYSA-N 0.000 claims description 11
- 239000000243 solution Substances 0.000 claims description 9
- 238000003756 stirring Methods 0.000 claims description 4
- 239000003292 glue Substances 0.000 claims description 2
- 238000001879 gelation Methods 0.000 claims 1
- 239000000203 mixture Substances 0.000 claims 1
- QQONPFPTGQHPMA-UHFFFAOYSA-N propylene Natural products CC=C QQONPFPTGQHPMA-UHFFFAOYSA-N 0.000 claims 1
- -1 propylene Amide Chemical class 0.000 claims 1
- 239000012620 biological material Substances 0.000 abstract description 4
- 230000008569 process Effects 0.000 abstract description 2
- 239000000126 substance Substances 0.000 abstract description 2
- 208000031737 Tissue Adhesions Diseases 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 230000000704 physical effect Effects 0.000 abstract 1
- 239000000853 adhesive Substances 0.000 description 18
- 230000001070 adhesive effect Effects 0.000 description 18
- 239000003431 cross linking reagent Substances 0.000 description 12
- 238000002156 mixing Methods 0.000 description 11
- 210000001519 tissue Anatomy 0.000 description 9
- 239000004971 Cross linker Substances 0.000 description 8
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 7
- 238000012360 testing method Methods 0.000 description 6
- 239000012153 distilled water Substances 0.000 description 5
- 229920003023 plastic Polymers 0.000 description 5
- 239000004033 plastic Substances 0.000 description 5
- 238000002791 soaking Methods 0.000 description 5
- 238000005406 washing Methods 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- 229910052925 anhydrite Inorganic materials 0.000 description 4
- 230000000052 comparative effect Effects 0.000 description 4
- 230000007547 defect Effects 0.000 description 4
- 239000003999 initiator Substances 0.000 description 4
- 210000000578 peripheral nerve Anatomy 0.000 description 4
- 229920002401 polyacrylamide Polymers 0.000 description 4
- 230000008439 repair process Effects 0.000 description 4
- 238000005303 weighing Methods 0.000 description 3
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- 235000010443 alginic acid Nutrition 0.000 description 2
- 229920000615 alginic acid Polymers 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- 229920002674 hyaluronan Polymers 0.000 description 2
- 229960003160 hyaluronic acid Drugs 0.000 description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 2
- 230000005847 immunogenicity Effects 0.000 description 2
- 210000000944 nerve tissue Anatomy 0.000 description 2
- 229920003229 poly(methyl methacrylate) Polymers 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 239000004926 polymethyl methacrylate Substances 0.000 description 2
- 229920002451 polyvinyl alcohol Polymers 0.000 description 2
- 230000008929 regeneration Effects 0.000 description 2
- 238000011069 regeneration method Methods 0.000 description 2
- 229920001059 synthetic polymer Polymers 0.000 description 2
- 230000017423 tissue regeneration Effects 0.000 description 2
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 description 1
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 1
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 208000010886 Peripheral nerve injury Diseases 0.000 description 1
- 229940072056 alginate Drugs 0.000 description 1
- 229960001126 alginic acid Drugs 0.000 description 1
- 239000000783 alginic acid Substances 0.000 description 1
- 150000004781 alginic acids Chemical class 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 230000008827 biological function Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 229910001424 calcium ion Inorganic materials 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 230000012292 cell migration Effects 0.000 description 1
- 229940045110 chitosan Drugs 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 238000013329 compounding Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 231100000433 cytotoxic Toxicity 0.000 description 1
- 230000001472 cytotoxic effect Effects 0.000 description 1
- 230000003013 cytotoxicity Effects 0.000 description 1
- 231100000135 cytotoxicity Toxicity 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 238000012377 drug delivery Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 210000002744 extracellular matrix Anatomy 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 229920001477 hydrophilic polymer Polymers 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 229920005615 natural polymer Polymers 0.000 description 1
- 231100001083 no cytotoxicity Toxicity 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 238000010526 radical polymerization reaction Methods 0.000 description 1
- 239000012966 redox initiator Substances 0.000 description 1
- 210000003497 sciatic nerve Anatomy 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 239000003106 tissue adhesive Substances 0.000 description 1
- 229940075469 tissue adhesives Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/16—Macromolecular materials obtained by reactions only involving carbon-to-carbon unsaturated bonds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/20—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/52—Hydrogels or hydrocolloids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/56—Porous materials, e.g. foams or sponges
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2430/00—Materials or treatment for tissue regeneration
- A61L2430/32—Materials or treatment for tissue regeneration for nerve reconstruction
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Transplantation (AREA)
- Dermatology (AREA)
- Medicinal Chemistry (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Dispersion Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Materials For Medical Uses (AREA)
Abstract
The invention belongs to the field of medical biomaterials capable of being implanted into a human body, and discloses a viscous hydrogel material, a suture-free artificial nerve conduit and a preparation method thereof. The invention combines the viscous hydrogel material with the tissue adhesion function and the chitosan artificial nerve conduit, and provides the suture-free artificial nerve conduit which is free from manual operation suture and convenient to use. The viscous hydrogel material bonded on the end side of the suturing-free artificial nerve conduit has good histocompatibility and mechanical property, can be strongly bonded with the wet tissue surface through physical action and chemical bonding, and can avoid the complicated suturing process when the conduit is implanted in an operation. In order to prepare the suture-free artificial nerve conduit, the invention also discloses a preparation method which is simple and feasible and is suitable for production.
Description
Technical Field
The invention belongs to the field of medical biomaterials capable of being implanted into a human body, and particularly relates to a viscous hydrogel material, a suture-free artificial nerve conduit and a preparation method thereof.
Background
In China, the number of peripheral nerve injury patients tends to increase year by year. Although peripheral nerves have a certain self-repair function, complete self-repair, particularly long-distance nerve defects, is difficult to achieve, and thus repair by means of various nerve bridges is required. Although autologous scaffolds are the gold standard for repairing peripheral nerve defects, they suffer from limited donor source, size mismatch and permanent damage to the site of extraction. At present, people mainly realize nerve repair by means of various tissue engineering nerve bridges prepared from natural or synthetic biomaterials with better biocompatibility and biodegradability. However, the speed of these artificial nerve grafts to promote peripheral nerve regeneration is still difficult to meet clinical needs, especially to repair nerve defects over long distances. Therefore, the development of a novel nerve graft which can promote peripheral nerve regeneration quickly and realize long-distance nerve defect repair is of great scientific significance.
Hydrogels are highly cross-linked hydrophilic polymers, structurally similar to the natural extracellular matrix, with good biocompatibility, have been widely studied, and have been applied in the medical field. Naturally occurring polymers such as chitosan, alginate, Hyaluronic Acid (HA), collagen and gelatin, etc., have biodegradability but suffer from poor mechanical properties, immunogenicity and batch-to-batch variability. While synthetic polymers such as polyethylene glycol (PEG), Polyacrylamide (PAM), poly (vinyl alcohol) (PVA), and Polymethylmethacrylate (PMMA) generally have better mechanical properties and low immunogenicity, but lack biological functions. Therefore, the hydrogel formed by compounding natural and synthetic polymers can meet the application in vivo.
Adhesion to wet and dynamic surfaces, including biological tissue, is important in many areas and adhesives that can strongly adhere to biological tissue will have a wide range of applications, from tissue repair and drug delivery. However, existing tissue adhesives are far from ideal, or are cytotoxic, poorly tissue compatible, or have poor adhesion to moist tissue surfaces. Therefore, there is an urgent need to develop biomaterials having good adhesion and tissue compatibility on wet tissue surfaces.
Disclosure of Invention
In view of the above, the present invention aims to provide a viscous hydrogel material, a suture-free artificial nerve conduit and a preparation method thereof. The adhesive hydrogel material can realize the adhesion of the artificial nerve conduit and the surface of the wet and dynamic tissue, does not need to be sutured, and is convenient to use.
In order to realize the purpose of the invention, the invention adopts the following technical scheme:
a method of preparing a viscous hydrogel material, comprising:
1) dissolving chitosan, sodium alginate and acrylamide in MES buffer solution to obtain mixed solution;
2) adding 1- (3-dimethylaminopropyl) -3-ethylcarbodiimide hydrochloride and N-hydroxysuccinimide into the mixed solution, stirring and mixing uniformly, and then adding N, N' -methylene bisacrylamide, tetramethylethylenediamine, ammonium persulfate and CaSO4And stirring for 0.5-1 h at room temperature to obtain the viscous hydrogel material.
Preferably, the MES buffer has a pH of 5.
Preferably, the content of each component in the mixed solution is as follows:
more preferably, the content of each component in the mixed solution is as follows:
preferably, the 1- (3-dimethylaminopropyl) -3-ethylcarbodiimide hydrochloride used in the step (2) is added in an amount of 0.12g per 1mL of the mixed solution; the using amount of the N-hydroxysuccinimide is 0.12g per 1mL of the mixed solution; the using amount of the N, N '-methylene-bisacrylamide is that 3.6 mu L of N, N' -methylene-bisacrylamide with the concentration of 20g/L is added into each 1mL of the mixed solution; the usage amount of the tetramethylethylenediamine is that 0.8 mu L of the tetramethylethylenediamine is added into each 1mL of the mixed solution; the dosage of the ammonium persulfate is 22.6 mu L of ammonium persulfate with the concentration of 0.27M added into each 1mL of the mixed solution; CaSO4In an amount of 19. mu.L of 0.75M CaSO per 1mL of the mixed solution4。
According to the invention, N' -methylene bisacrylamide is added as a cross-linking agent during preparation of the viscous hydrogel, and in a redox initiation system consisting of tetramethylethylenediamine and ammonium persulfate, free radical polymerization reaction is carried out on acrylamide to form polyacrylamide, and activated hydroxyl in sodium alginate can form an amido bond with polyacrylamide, so that the mechanical property of the chitosan hydrogel can be enhanced, and the chitosan hydrogel can be rapidly molded in the preparation process. In addition, CaSO4The calcium ion in the solution is coupled with the alginic acid in the sodium alginate solution to form a cross-linked network, and the viscous crystal glue material can be quickly molded in a mold.
The invention also provides a viscous hydrogel material prepared by the preparation method.
The adhesive hydrogel is of a porous structure, has no cytotoxicity, is favorable for exchange of nutrient substances inside and outside the nerve conduit, cell migration and tissue regeneration, and has strong histocompatibility.
The invention also provides a suture-free artificial nerve conduit, which comprises a chitosan artificial nerve conduit and adhesive hydrogel respectively adhered to the two end parts of the chitosan artificial nerve conduit, wherein the adhesive hydrogel is formed by gelatinizing the adhesive hydrogel material.
The invention also provides a preparation method of the suture-free artificial nerve conduit, which comprises the following steps:
(1) placing the chitosan artificial nerve conduit into a mould, and reserving vacant spaces with the lengths of 1-2 cm at two ends of the mould;
(2) injecting the viscous hydrogel material to two ends of the chitosan artificial nerve conduit placed in the mold before gelling, placing for 12-24 h, and removing the mold after the viscous hydrogel material naturally gels to obtain the suture-free artificial nerve conduit.
Preferably, the mold is matched with the inner diameter and the outer diameter of the chitosan artificial nerve conduit.
Preferably, the length of the chitosan artificial nerve conduit is 5 mm.
The present invention also provides a suture-free artificial nerve conduit characterized by being prepared by adhering the adhesive porous hydrogel of claim 1 or 2 to both ends of a chitosan artificial nerve conduit, respectively.
Compared with the prior art, in the preparation method of the viscous hydrogel disclosed by the invention, chitosan, sodium alginate and acrylamide are mixed, 1- (3-dimethylaminopropyl) -3-ethylcarbodiimide hydrochloride and N-hydroxysuccinimide are added and mixed uniformly, and then N, N' -methylenebisacrylamide, tetramethylethylenediamine, ammonium persulfate and CaSO are added4The obtained viscous hydrogel material has a porous structure, is free from cytotoxicity, has good biocompatibility and is suitable for being implanted into a body. In addition, 1- (3-dimethylaminopropyl) -3-ethylcarbodiimide hydrochloride and N-hydroxysuccinimide added in the preparation process of the viscous hydrogel material can activate carboxyl in sodium alginate, and then can form amido bond with chitosan and amino in human tissues to form a cross-linked network. Therefore, the viscous hydrogel material is injected to the positions of two ends in a mould with the chitosan artificial nerve conduit before gelling, hydroxyl in sodium alginate forms amido bond with chitosan, and the chitosan artificial nerve conduit is strongly bonded and molded at the position of the end of the chitosan nerve conduit to prepare the suture-free artificial nerve conduit. When the suturing-free artificial nerve conduit is implanted in a use process, such as a nerve conduit operation, the viscous hydrogel can strongly adhere to nerve tissues by forming an amido bond with amino in the nerve tissues, so that the effect of avoiding operation suturing is achieved, and the use is convenient.
Detailed Description
For a further understanding of the invention, reference will now be made to the preferred embodiments of the present invention by way of example, and it is to be understood that the description is intended to further illustrate features and advantages of the present invention and is not intended to limit the scope of the claims which follow.
All of the starting materials of the present invention, without particular limitation as to their source, may be purchased commercially or prepared according to conventional methods well known to those skilled in the art.
Example 1
1) 1L of MES buffer was prepared and the pH was adjusted to 5.
2) And (3) weighing 20g of chitosan, 20g of sodium alginate and 120g of acrylamide, and dissolving in the prepared MES buffer solution to obtain a mixed solution.
3) 120g of amino crosslinker 1- (3-dimethylaminopropyl) -3-ethylcarbodiimide hydrochloride (EDC) and 120g of N-hydroxysuccinimide (NHS) are added to the mixed solution, after mixing, 3.6mL of a covalent crosslinking agent N, N' -Methylenebisacrylamide (MBAA) with a concentration of 20g/L, 0.8mL of an accelerator Tetramethylethylenediamine (TEMED), 22.6mL of an initiator Ammonium Persulfate (APS) with a concentration of 0.27M and 19.1mL of an ionic crosslinking agent CaSO with a concentration of 0.75M are added4And uniformly mixing to obtain the viscous hydrogel material.
5) The chitosan artificial nerve conduit is placed into a plastic mould with matched inner and outer diameters, and 2cm of space is reserved at two ends.
6) Before the viscous hydrogel material is not gelatinized, the viscous hydrogel material is injected into the vacant spaces at the two ends of the chitosan catheter, and is placed for 12 hours to be gelatinized naturally.
7) And (4) disassembling the die, and soaking and washing in distilled water to remove the uncrosslinked cross-linking agent and acrylamide.
Example 2
1) 1L of MES buffer was prepared and the pH was adjusted to 5.
2) 30g of chitosan, 30g of sodium alginate and 120g of acrylamide are weighed and dissolved in the prepared MES buffer solution to obtain a mixed solution.
3) 120g of amino crosslinker 1- (3-dimethylaminopropyl) -3-ethylcarbodiimide hydrochloride (EDC) and 120g of N-hydroxysuccinimide (NHS) are added to the mixed solution, after mixing, 3.6mL of a covalent crosslinking agent N, N' -Methylenebisacrylamide (MBAA) with a concentration of 20g/L, 0.8mL of an accelerator Tetramethylethylenediamine (TEMED), 22.6mL of an initiator Ammonium Persulfate (APS) with a concentration of 0.27M and 19.1mL of an ionic crosslinking agent CaSO with a concentration of 0.75M are added4And uniformly mixing to obtain the viscous hydrogel material.
5) The chitosan artificial nerve conduit is placed into a plastic mould with matched inner and outer diameters, and 2cm of space is reserved at two ends.
6) Before the hydrogel is not gelatinized, the hydrogel is injected into the vacant spaces at the two ends of the chitosan catheter, and the chitosan catheter is placed for 18h to naturally gelatinize.
7) And (4) disassembling the die, and soaking and washing in distilled water to remove the uncrosslinked cross-linking agent and acrylamide.
Example 3
1) 1L of MES buffer was prepared and the pH was adjusted to 5.
2) 10g of chitosan, 10g of sodium alginate and 70g of acrylamide are weighed and dissolved in the prepared MES buffer solution to obtain a mixed solution.
3) 120g of amino crosslinker 1- (3-dimethylaminopropyl) -3-ethylcarbodiimide hydrochloride (EDC) and 120g of N-hydroxysuccinimide (NHS) are added to the mixed solution, after mixing, 3.6mL of a covalent crosslinking agent N, N' -Methylenebisacrylamide (MBAA) with a concentration of 20g/L, 0.8mL of an accelerator Tetramethylethylenediamine (TEMED), 22.6mL of an initiator Ammonium Persulfate (APS) with a concentration of 0.27M and 19.1mL of an ionic crosslinking agent CaSO with a concentration of 0.75M are added4Mixing to obtain viscous hydrogelA material.
5) The chitosan artificial nerve conduit is placed into a plastic mould with matched inner and outer diameters, and 2cm of space is reserved at two ends.
6) Before the hydrogel is not gelatinized, the hydrogel is injected into the vacant spaces at the two ends of the chitosan catheter, and the chitosan catheter is placed for 24 hours to naturally gelatinize.
7) And (4) disassembling the die, and soaking and washing in distilled water to remove the uncrosslinked cross-linking agent and acrylamide.
Comparative example 1
1) 1L of MES buffer was prepared and the pH was adjusted to 5.
2) And (3) weighing 20g of chitosan, 20g of sodium alginate and 120g of acrylamide, and dissolving in the prepared MES buffer solution to obtain a mixed solution.
3) 120g of amino crosslinker 1- (3-dimethylaminopropyl) -3-ethylcarbodiimide hydrochloride (EDC) and 120g of N-hydroxysuccinimide (NHS) were added to the mixed solution, and after mixing, 0.8mL of accelerator Tetramethylethylenediamine (TEMED), 22.6mL of initiator Ammonium Persulfate (APS) having a concentration of 0.27M and 19.1mL of ionic crosslinker CaSO having a concentration of 0.75M were added4And uniformly mixing to obtain the viscous hydrogel material.
5) The chitosan artificial nerve conduit is placed into a plastic mould with matched inner and outer diameters, and 2cm of space is reserved at two ends.
6) Before the viscous hydrogel material is not gelatinized, the viscous hydrogel material is injected into the vacant spaces at the two ends of the chitosan catheter, and is placed for 18h to be gelatinized naturally.
7) And (4) disassembling the die, and soaking and washing in distilled water to remove the uncrosslinked cross-linking agent and acrylamide.
Comparative example 2
1) 1L of MES buffer was prepared and the pH was adjusted to 5.
2) And (3) weighing 20g of chitosan, 20g of sodium alginate and 120g of acrylamide, and dissolving in the prepared MES buffer solution to obtain a mixed solution.
3) 120g of amino crosslinker 1- (3-dimethylaminopropyl) -3-ethylcarbodiimide hydrochloride (EDC) and 120g of N-hydroxysuccinimide (NHS) were added to the mixed solution, and after mixing, 3.6mL of covalent crosslinker N, N' -Methylenebisacrylamide (MBAA) with a concentration of 20g/L was added) 0.8mL of accelerator Tetramethylethylenediamine (TEMED) and 19.1mL of 0.75M ionic crosslinker CaSO4And uniformly mixing to obtain the viscous hydrogel material.
5) The chitosan artificial nerve conduit is placed into a plastic mould with matched inner and outer diameters, and 2cm of space is reserved at two ends.
6) Before the viscous hydrogel material is not gelatinized, the viscous hydrogel material is injected into the vacant spaces at the two ends of the chitosan catheter, and is placed for 40h to be gelatinized naturally.
7) And (4) disassembling the die, and soaking and washing in distilled water to remove the uncrosslinked cross-linking agent and acrylamide.
Test example: adhesive hydrogel adhesion test
Rat sciatic nerves were inserted into 1mm of the adhesive hydrogel at both ends of the suture-free artificial nerve conduit prepared in examples 1-3 of the present invention, and fixed with surgical forceps under a humid condition at 37 ℃ for 10 min. The test was performed using a universal mechanical testing machine (TFW-58, Shanghai Tuofeng Instrument Technology co.ltd., China) at a crosshead speed of 0.5mm/min, with the test results shown in table 1.
TABLE 1 adhesion of artificial nerve conduits to nerves
According to the test results in Table 1, the adhesive force of the adhesive hydrogels at two ends of the suturing-free artificial nerve conduit provided by the embodiment and the comparative example is 0.01-0.1 MPa, wherein the adhesive force of the adhesive hydrogels at two ends of the suturing-free artificial nerve conduit prepared by the embodiment 1 (the concentration is 20g/L of chitosan; 20g/L of sodium alginate; 20g/L of acrylamide; 120g/L) is the strongest to nerve, and can reach 0.1 MPa. In addition, it was found according to the comparative example that removal of Tetramethylethylenediamine (TEMED) resulted in a decrease in adhesive force of the adhesive porous hydrogel, and that removal of Ammonium Persulfate (APS) resulted in substantially no decrease in adhesive force of the adhesive hydrogel, but resulted in an increase in gel formation time.
While there have been shown and described what are at present considered the fundamental principles and essential features of the invention and its advantages, it will be apparent to those skilled in the art that the invention is not limited to the details of the foregoing exemplary embodiments, but is capable of other specific forms without departing from the spirit or essential characteristics thereof. The present embodiments are therefore to be considered in all respects as illustrative and not restrictive, the scope of the invention being indicated by the appended claims rather than by the foregoing description, and all changes which come within the meaning and range of equivalency of the claims are therefore intended to be embraced therein. Although embodiments of the present invention have been shown and described, it will be appreciated by those skilled in the art that changes, modifications, substitutions and alterations can be made in these embodiments without departing from the principles and spirit of the invention, the scope of which is defined in the appended claims and their equivalents.
Claims (4)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201910874185.1A CN110448727B (en) | 2019-09-17 | 2019-09-17 | A kind of viscous hydrogel material, suture-free artificial nerve conduit and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201910874185.1A CN110448727B (en) | 2019-09-17 | 2019-09-17 | A kind of viscous hydrogel material, suture-free artificial nerve conduit and preparation method thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN110448727A CN110448727A (en) | 2019-11-15 |
| CN110448727B true CN110448727B (en) | 2021-10-19 |
Family
ID=68492106
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201910874185.1A Active CN110448727B (en) | 2019-09-17 | 2019-09-17 | A kind of viscous hydrogel material, suture-free artificial nerve conduit and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN110448727B (en) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20230058182A1 (en) * | 2020-01-23 | 2023-02-23 | Korea University Research And Business Foundation | Nerve suture patch having self-healing property and production method thereof |
| CN111450318B (en) * | 2020-03-26 | 2022-05-17 | 南通大学 | Chitosan nerve conduit for bridging nerve tissue by light and its preparation method and application |
| CN116531560B (en) * | 2023-06-16 | 2025-07-25 | 南通大学 | Thermo-sensitive rotator cuff self-locking nerve conduit and preparation method thereof |
Citations (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1586431A (en) * | 2004-10-15 | 2005-03-02 | 赵林森 | Absorptive nervous catheter and its producing method |
| AU2006289625A1 (en) * | 2005-09-09 | 2007-03-15 | Ottawa Health Research Institute | Interpenetrating networks, and related methods and compositions |
| CN101622004A (en) * | 2006-12-04 | 2010-01-06 | 约翰·霍普金斯大学 | Imidized biopolymer adhesives and hydrogels |
| CN102596275A (en) * | 2009-09-04 | 2012-07-18 | 亚洲大学校产学协力团 | In situ-forming hydrogel for tissue adhesives and biomedical use thereof |
| CN105194740A (en) * | 2015-09-20 | 2015-12-30 | 哈尔滨工业大学 | Postoperation anti-adhesion hydrogel and preparing method thereof |
| CN108264611A (en) * | 2018-01-30 | 2018-07-10 | 江汉大学 | A kind of preparation method from the superpower hydrogel of adherency |
| CN109503864A (en) * | 2018-12-04 | 2019-03-22 | 上海其胜生物制剂有限公司 | One kind has the preparation method of the injection aquagel of cohesion enhancing characteristic |
| US20190091367A1 (en) * | 2016-03-22 | 2019-03-28 | President And Fellows Of Harvard College | Biocompatible adhesives and methods of use thereof |
-
2019
- 2019-09-17 CN CN201910874185.1A patent/CN110448727B/en active Active
Patent Citations (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1586431A (en) * | 2004-10-15 | 2005-03-02 | 赵林森 | Absorptive nervous catheter and its producing method |
| AU2006289625A1 (en) * | 2005-09-09 | 2007-03-15 | Ottawa Health Research Institute | Interpenetrating networks, and related methods and compositions |
| CN101622004A (en) * | 2006-12-04 | 2010-01-06 | 约翰·霍普金斯大学 | Imidized biopolymer adhesives and hydrogels |
| CN102596275A (en) * | 2009-09-04 | 2012-07-18 | 亚洲大学校产学协力团 | In situ-forming hydrogel for tissue adhesives and biomedical use thereof |
| US8968716B2 (en) * | 2009-09-04 | 2015-03-03 | Ajou University Industry-Academic Cooperation Foundation | In situ-forming hydrogel for tissue adhesives and biomedical use thereof |
| CN105194740A (en) * | 2015-09-20 | 2015-12-30 | 哈尔滨工业大学 | Postoperation anti-adhesion hydrogel and preparing method thereof |
| US20190091367A1 (en) * | 2016-03-22 | 2019-03-28 | President And Fellows Of Harvard College | Biocompatible adhesives and methods of use thereof |
| CN108264611A (en) * | 2018-01-30 | 2018-07-10 | 江汉大学 | A kind of preparation method from the superpower hydrogel of adherency |
| CN109503864A (en) * | 2018-12-04 | 2019-03-22 | 上海其胜生物制剂有限公司 | One kind has the preparation method of the injection aquagel of cohesion enhancing characteristic |
Also Published As
| Publication number | Publication date |
|---|---|
| CN110448727A (en) | 2019-11-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN110240712B (en) | A kind of high tensile, high viscosity, self-healing double network hydrogel for tissue adhesion and preparation method and application thereof | |
| CN102325814B (en) | Preparing biodgradable hydrogel for biomedical application | |
| CN108478867B (en) | Injectable polymer hydrogel based on acylhydrazone bond, its preparation method and polymer hydrogel injection | |
| CN112062981B (en) | A kind of preparation method of medium-mediated cross-linking hyaluronic acid-based double cross-linking hydrogel | |
| JP5105274B2 (en) | Biocompatible cross-linked gel | |
| CN106310383B (en) | Injectable bone repair hydrogel and preparation method thereof | |
| KR101250543B1 (en) | Hydrgel, preparation method and use thereof | |
| JP6456285B2 (en) | Selective polymerizable composition and method of use in vivo | |
| Wang et al. | Fiber-reinforced silk microneedle patches for improved tissue adhesion in treating diabetic wound infections | |
| CN110448727B (en) | A kind of viscous hydrogel material, suture-free artificial nerve conduit and preparation method thereof | |
| JP2003508564A (en) | Composition forming an interpenetrating polymer network for use as a high strength medical sealant | |
| TW200410987A (en) | Method for producing a double-crosslinked hyaluronate material | |
| CN110935058A (en) | Double-component medical glue for rapid hemostasis and preparation method thereof | |
| CN112341640A (en) | Bio-based self-repairing hydrogel and preparation method and application thereof | |
| CN115554462B (en) | Anti-swelling injectable hydrogel adhesive and preparation method thereof | |
| CN101891946A (en) | A kind of enhanced biological hydrogel with DN-L structure and its preparation method | |
| CN108498847A (en) | Macromolecule hydrogel, preparation method based on acylhydrazone key and skin histology adhesive | |
| Salehi Dashtebayaz et al. | Interpenetrating networks hydrogels based on hyaluronic acid for drug delivery and tissue engineering | |
| JP2009522001A (en) | Photocurable bone growth material for treating dental bone defects | |
| US10342894B2 (en) | Hydrogel composites, compositions, and methods | |
| CN112143410B (en) | Injectable biological adhesive and preparation method and application thereof | |
| CN118359775A (en) | Degradable, adhesive, self-healing in-situ injectable organogel and preparation method thereof | |
| CN110680959B (en) | Hydrogel for repairing multiple cross-linked meniscus and preparation method thereof | |
| CN110755685A (en) | 3D printing guar gum gel bracket and preparation method thereof | |
| CN114796609A (en) | Application of polyethylene glycol hydrogel in preparation of self-adhesive biomedical material |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant |